Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT07687459 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

320

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: INS018_055 tablets
DRUG: Placebo

Sponsor

InSilico Medicine Hong Kong Limited